Ontario can boast exciting, innovative and transformational life sciences companies and organizations. Read @LifeSciencesON's Success Stories 2026. CCRM is pleased to be featured again this year. Find us on page 12 and check out #OmniaBio on page 38.
https://t.co/fjFCLgT8Ng
How good are you at making predictions? Blogger Cal Strode checks in on some #iPSC predictions made in 2016 as the #stemcell field celebrates 20 years of progress. https://t.co/D3S4E08Udl @ISSCR@KyotoU_News
Researchers are learning to crack the blood-brain barrier to get drugs more easily into the brain. This has opened doors for treating a rare genetic disorder and is being tested in Phase 3 trials for Alzheimer's.
My latest in @NatGeo: https://t.co/ScpsPKuG8g
Women are most commonly diagnosed with #dysautonomia. What is it & can #stemcells make a difference in treating the improper functioning of the autonomic nervous system? Ellie Kroeger explores the efficacy of treating it with MSCs https://t.co/Z8NwcsgGgQ
A recent #deeptech event in Toronto suggests there is optimism that #quantumcomputing can have a meaningful impact on accelerating the commercialization of cell and gene therapies. Read @msstaceyerin's blog post https://t.co/M28HlwiM3T #DeepTechBioLab
Don't forget to vote for the #CellsISee People's Choice Award by October 7, 2026. #Sciart#contest hosted by CCRM and @StemCellNetwork
Vote here: https://t.co/oKP2kc6ATg
A fifth cell and gene therapy product has been approved in the US this year.
Today, the FDA announced approval of an AAV gene therapy developed by ARM member Ultragenyx to treat pediatric patients with Sanfilippo syndrome Type A. 1/2
https://t.co/icwC3ApDJI
ICYMI: my call for Japan to do more to stop its huge & growing unproven stem cell/regenerative clinic industry after some deaths and many adverse events https://t.co/YNVlp0FiZV @ISSCR@ISCTglobal@CaulfieldTim@Signalsblogs
How do we make CGTs more accessible to patients globally? In the new episode of our podcast, @bambi_grilley & #StaciArnold explore manufacturing & delivery challenges, regulation, P3s & more. Listen where you stream podcasts or at https://t.co/xFPIF5LSsK. @KristaLambComms
📣 Signals is looking for talented bloggers to write about the #regenerativemedicine and #CGT fields. https://t.co/T6iLk6T5tp
If you’re passionate about cutting-edge science and can turn complex ideas into compelling content, we want to hear from you. DM us to learn more #scicomm
The 2026 #CellsISee People’s Choice Award voting is now open! "Like" your favourite and the lucky winner will receive $500 at #TMM2026. The #sciart#contest is co-hosted with @StemCellNetwork Vote here: https://t.co/HaWmUnm6Ed Pls RT
🤩 Hope you're excited for our next guest, Dr. Yonatan Stelzer at @WeizmannScience!
The Stelzer Lab investigates how cell fate and identity are established during #embryonic development using single-cell and epigenomic approaches. 🧫
Check out his latest work: https://t.co/xjol0o5IoU
Inspiring Canada’s next generation of thinkers and problem-solvers starts with empowering educators! Our expanded free, bilingual STEM programming suite gives teachers even more turnkey, Canadian-context tools to bring into their classrooms. Read more:https://t.co/L57DmcK8A7
Scientists stress-tested genes across 22 million human immune cells—using real cells from real donors, not lab models.
Emma Dann & Ronghui Zhu break down why this massive new dataset could reshape cancer immunotherapy and autoimmune treatment.
https://t.co/CzDEQfLtlQ